Transfer

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

central cancer cell being attacked by surrounding immune cells (t-cells). Ideal for medical, scientific, oncology, and health-related content

Transfer, Molecular Targets and Therapeutics, VIRO,

Helmholtz Munich Technologies and Champalimaud Foundation TCR Assets Support Cellular Immunotherapy Research

Helmholtz Munich has licensed fusion receptor technologies to the Champalimaud Foundation, where they are being used together with newly acquired T cell receptor assets to support research into engineered T cell therapies.

M1 Medicine Alliance - Funded Projects

Transfer, Diabetes, IDC, Stem Cells, ISF,

M1 Launches First Funding Period and Advances Translation in Munich

With the launch of its first funding period, the M1 – Munich Medicine Alliance is entering its active translation phase in Munich. As part of the “Innovations for Patients” program, the alliance is funding seven research projects with a total of…

EMBO Workshop Biomedical Engineering

Transfer, Bioengineering, IBMI,

Biomedical Engineering: Science Translation for Future Health

Biomedical engineering applies engineering principles to address challenges in medicine and biology. To explore ways of strengthening biomedical engineering as a driver of innovation and growth in Europe, EMBO and the Helmholtz Bioengineering…

Kidney Picture AI-Generated

AI, Transfer, Computational Health, ICB,

Helmholtz Munich Launches Collaboration on AI-Driven Kidney Disease Research

Helmholtz Munich and Novartis Biomedical Research are launching a four-year collaboration to advance kidney disease research. Starting in early 2026, the partnership will work to develop an integrated, cross-species “kidney disease atlas” at…

Nurse and patient in hospital bed with medical monitors

Transfer, Diabetes, HI-MAG,

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading clinics across Germany to translate research findings directly and purposefully into new therapeutic approaches — and,…

Helmholtz Biomedical Engineering Initiative

AI, Transfer, Bioengineering, IBMI, Pioneer Campus,

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…